Mosaic ImmunoEngineering (CPMV, $0.65) was a top loser over the last three months, falling -3 to $0.65 per share. A.I.dvisor analyzed 844 stocks in the Biotechnology Industry for the 3-month period ending April 24, 2025, and found that of them (2) exhibited an Uptrend while of them (7) demonstrated a Downtrend.